Suppr超能文献

肝硬化患者的肾上腺功能不全:108例病例系列评估

Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series.

作者信息

Rakici Hali

机构信息

Department of Gastroenterology, Recep Tayyip Erdogan Universitesi, Riza, Turkey.

出版信息

Euroasian J Hepatogastroenterol. 2017 Jul-Dec;7(2):150-153. doi: 10.5005/jp-journals-10018-1237. Epub 2017 Sep 29.

Abstract

AIM

Adrenal insufficiency (AI) in cirrhosis is an issue that has recently gained momentum. It can be seen in both stable and critically ill (sepsis, septic shock, and gastrointestinal system bleeding) cirrhotic patients. Its prevalence exists in a wide range since standardization of diagnostic methods is lacking. We aimed to scrutinize this issue in a 108 case series.

MATERIALS AND METHODS

We studied the presence of AI and its stage in patients with cirrhosis and its complications by using cross-sectional study. Standard-dose short synacthen test (SD-SST) was performed in 108 patients that had Child C decompensated cirrhosis without critical illness and it was aimed to determine the prevalence of AI based on basal cortisol, peak cortisol, and delta cortisol (basal total cortisol minus peak cortisol after stimulation) levels.

RESULTS

The prevalence of AI in cirrhosis was found to be 25% based on basal cortisol level of <140 nmol/L, 22.2% based on delta cortisol level of <250 nmol/L, and 29.6% based on peak cortisol level of <500 nmol/L.

CONCLUSION

Prevalence of AI shows variation in decompensated cirrhosis without critical illness depending on different measures used. More definite results can be obtained when more standardized criteria are widely put into use. Rakici H. Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series. Euroasian J Hepato-Gastroenterol 2017;7(2):150-153.

摘要

目的

肝硬化患者的肾上腺功能不全(AI)是一个最近受到关注的问题。在病情稳定和危重症(脓毒症、感染性休克和胃肠道出血)的肝硬化患者中均可出现。由于缺乏标准化的诊断方法,其患病率范围较广。我们旨在通过一个包含108例患者的病例系列来仔细研究这一问题。

材料与方法

我们采用横断面研究,对肝硬化及其并发症患者中AI的存在情况及其阶段进行了研究。对108例Child C级失代偿性肝硬化且无危重症的患者进行了标准剂量短程促肾上腺皮质激素试验(SD-SST),旨在根据基础皮质醇、峰值皮质醇和增量皮质醇(基础总皮质醇减去刺激后峰值皮质醇)水平来确定AI的患病率。

结果

基于基础皮质醇水平<140 nmol/L,肝硬化患者中AI的患病率为25%;基于增量皮质醇水平<250 nmol/L,患病率为22.2%;基于峰值皮质醇水平<500 nmol/L,患病率为29.6%。

结论

在无危重症的失代偿性肝硬化患者中,根据所采用的不同测量方法,AI的患病率存在差异。当更广泛地采用更标准化的标准时,可以获得更明确的结果。拉基奇H。肝硬化患者的肾上腺功能不全:108例病例系列评估。《欧亚肝脏胃肠病学杂志》2017年;7(2):150 - 153。

相似文献

1
Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series.肝硬化患者的肾上腺功能不全:108例病例系列评估
Euroasian J Hepatogastroenterol. 2017 Jul-Dec;7(2):150-153. doi: 10.5005/jp-journals-10018-1237. Epub 2017 Sep 29.

引用本文的文献

5
Newly discovered endocrine functions of the liver.肝脏新发现的内分泌功能。
World J Hepatol. 2021 Nov 27;13(11):1611-1628. doi: 10.4254/wjh.v13.i11.1611.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验